Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2000
04/04/2000US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament
04/04/2000US6045804 Contacting a sample of body fluid with a solid substrate comprising an immobilized antigen which lacking a detectable level of outer surface protein a; detecting lyme disease
04/04/2000US6045758 Test sample card has a fluid passage network provided on both sides of the card to provide for maximum separation distance between adjacent growth wells; biological analysis
04/04/2000US6045754 The lid and tray are bent to open reagent wells and to form an a-shaped stand, structured so that the kit may be placed in a free-standing, upright position for use.
04/04/2000US6045727 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
04/04/2000US6045699 Serum obtained easily in a short period without leakage of blood cells and hemolysis by controlling the pressure difference between blood inlet side and filtrate outlet side; accuracy; medical diagnosis; potassium ion concentration
04/04/2000US6045673 Gas sensor for measuring oxides such as nitrogen oxides, sulfur dioxide, water and inflammable gases such as carbon monoxide or hydrocarbon gases contained in atmospheric air and exhaust gas discharge from automobiles
04/04/2000US6045541 Device for taking up fluid
04/04/2000US6044689 Apparatus for sensing low concentration NOx, chamber used for apparatus for sensing low concentration NOx; gas sensor element and method of manufacturing the same; and ammonia removing apparatus and NOx sensor utilizing this apparatus
04/04/2000CA2173878C Polynucleotide for treating systemic lupus erythematosus
04/04/2000CA2105402C Radiolabelled compound formulations
04/04/2000CA2072004C An hplc light-scattering detector for biopolymers
04/04/2000CA2065370C Factor viii:ca chromogenic assay
04/04/2000CA2045475C Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay
04/04/2000CA2009454C Detection of nucleic acid sequences by fluorescence polarization
03/2000
03/30/2000WO2000017808A1 Spectral bio-imaging data for cell classification using internal reference
03/30/2000WO2000017659A1 Cobalamin assay
03/30/2000WO2000017658A2 Diagnosis of myocardial disease or stroke using factor ix activation peptide
03/30/2000WO2000017657A1 A flow cytometric, whole blood dendritic cell immune function assay
03/30/2000WO2000017656A1 Water-soluble thiol-capped nanocrystals
03/30/2000WO2000017655A1 Water-soluble fluorescent semiconductor nanocrystals
03/30/2000WO2000017654A1 Assays for helminth infections
03/30/2000WO2000017653A2 Salmonella antigen formulation and kit for detecting salmonella antibodies
03/30/2000WO2000017652A1 Device for measuring migration capability of amoeboid moving cells
03/30/2000WO2000017651A1 Analytical test device and method of use
03/30/2000WO2000017650A1 Energy transfer compositions comprising phycobiliproteins
03/30/2000WO2000017649A1 Fluorescence polarization-based diagnostic assay for equine infectious anemia virus
03/30/2000WO2000017648A1 Apoptosis marker antibodies and methods of use
03/30/2000WO2000017647A1 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(CRYPTOSPORIDIUM PARVUM)
03/30/2000WO2000017646A1 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(ENTAMOEBA HISTOLYTICA)
03/30/2000WO2000017645A1 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(GIARDIA LAMBLIA)
03/30/2000WO2000017644A1 Ndp
03/30/2000WO2000017643A2 A system for cell-based screening
03/30/2000WO2000017642A2 Biological applications of semiconductor nanocrystals
03/30/2000WO2000017641A1 Gpr10 as a target for identifying weight modulating compounds
03/30/2000WO2000017640A1 Immunoassay for equine protozoal myeloencephalitis in horses
03/30/2000WO2000017639A1 Predictive assay for immune response
03/30/2000WO2000017638A1 Method, system and device for producing signals from a substance, in particular electric signals, characteristic of said substance biological and/or chemical activity
03/30/2000WO2000017636A1 Alcohol concentration test system
03/30/2000WO2000017635A1 Device for measuring vibration properties of a lubricant
03/30/2000WO2000017626A1 Analytical test device and method of use
03/30/2000WO2000017624A2 Miniaturized cell array methods and apparatus for cell-based screening
03/30/2000WO2000017623A2 A new hematological parameter
03/30/2000WO2000017622A1 Measuring the energy absorbing capacity of a substrate
03/30/2000WO2000017621A1 In-situ non-destructive elastic recovery tester
03/30/2000WO2000017611A1 Method and apparatus for process control
03/30/2000WO2000017402A1 Methods for identifying multiple primary targets of a drug
03/30/2000WO2000017398A1 Parallel selex
03/30/2000WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
03/30/2000WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
03/30/2000WO2000017390A1 Dna amplification of a single cell
03/30/2000WO2000017388A1 Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents
03/30/2000WO2000017387A1 Production and use of antimicrobial agents
03/30/2000WO2000017369A2 Alzheimer's disease secretase
03/30/2000WO2000017361A2 Interferon-epsilon
03/30/2000WO2000017360A1 Cystine knot growth factor mutants
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017353A1 Ucp4
03/30/2000WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
03/30/2000WO2000017348A1 G protein-coupled receptor agonists or antagonists
03/30/2000WO2000017343A1 Method for making insertional mutations
03/30/2000WO2000017329A1 Rec2 kinase
03/30/2000WO2000017327A2 Terpene synthases
03/30/2000WO2000017235A2 Cytokine receptor zalpha11
03/30/2000WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000WO2000017232A2 Regulatory protein from human keratinocytes
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017221A1 Method of measuring protein-protein interactions in living cells
03/30/2000WO2000017219A1 Detection of human herpes virus 6 (hhv6)
03/30/2000WO2000017103A2 Inventory control
03/30/2000WO2000016893A2 Bio-assay technique
03/30/2000WO2000016872A1 Methods and apparatus for processing temperature sensitive materials
03/30/2000WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000WO2000016803A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000002913B1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
03/30/2000WO2000000145A9 Disposable absorbent articles having translational operative members
03/30/2000WO1999067638A9 Method and reagents for detecting dystocia
03/30/2000WO1999067427A9 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/30/2000WO1999067393A3 Aav scleroprotein, production and use thereof
03/30/2000WO1999067288A9 Tumor antigen peptides originating in cyclophilin b
03/30/2000WO1999061608A3 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
03/30/2000WO1999061601A9 Aav5 vector and uses thereof
03/30/2000WO1999057565A3 Methods for diagnosing and evaluating cancer
03/30/2000WO1999057311A3 Novel method for the identification of clones conferring a desired biological property from an expression library
03/30/2000WO1999055913A9 Reduced complexity nucleic acid targets and methods of using same
03/30/2000WO1999053055A3 Therapeutic agent for ngf
03/30/2000WO1999051744A3 A interleukin-1 receptor antagonist and uses thereof
03/30/2000WO1999042477A3 Transporter protein for saccharide-coupled medicaments
03/30/2000WO1999038980A3 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/30/2000DE19944695A1 Method for strengthening the antitumor activity of a crude drug containing polysaccharides comprises roasting the crude drug by far infrared rays followed by fermentation using microorganisms
03/30/2000DE19942268A1 Use of fungal phosphatidylinositol 3-kinases, especially Candida albicans CaVps34p, to screen for antifungal agents
03/30/2000DE19855831A1 Hand-operated waste gas analyzer for determination of heating installation performance
03/30/2000DE19844500A1 Verfahren zur photometrischen Auswertung von Testelementen Method for the photometric analysis of test elements
03/30/2000DE19843988A1 Monitoring corona discharge treatment of plastic sheet is achieved by non-contact field strength measurement, in conjunction with electrodes discharging and re-charging it
03/30/2000DE19843750A1 Vorrichtung und Verfahren zur Analyse von chemischen Substratgehalten in einer Flüssigkeit Apparatus and method for analysis of chemical substrate held in a liquid
03/30/2000DE19843095A1 Appliance and method for measuring the ageing of foodstuffs by subjecting foodstuff to pulsed sound and electromagnetic waves
03/30/2000DE19833859C1 Verfahren zur Ermittlung der Farbtonstabilität von Lacken A method of determining the shade stability of coatings
03/30/2000DE19819677C2 Prüfgerät für Dieselkraftstoff Tester for diesel fuel
03/30/2000CA2689373A1 G protein-coupled receptor antagonists
1 ... 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 ... 3937